Ready to talk to India to resolve differences over CPEC: China

Agencies
January 29, 2018

Beijing, Jan 29: China on Monday said it is ready to hold talks with India to resolve their differences on the contentious China-Pakistan Economic Corridor (CPEC).

"I noted the relevant report. Regarding the CPEC, China has repeatedly reiterated our position. As to the differences between China and India, China stands ready to communicate and hold talks with India to seek a proper solution so that these differences will not affect our general national interests. This best serves the interests of the two countries," Chinese foreign ministry spokeswoman Hua Chunying said.

She was responding to Indian Ambassador to China Gautam Bambawale's interview to state-run Global Times in which he had said that differences on the CPEC should not be swept under the carpet,

"We should not ask one party alone to solve this problem. We are willing to work with India to work with dialogue and communication for a better solution," she added.

"CPEC is merely an economic cooperation project. It has not targeted any third party. We hope the Indian side can put this in perspective and we stand ready to strengthen cooperation with the Indian side," Hua said.

India has objected to the USD 50 billion CPEC as it passes through Pakistan-occupied Kashmir (PoK).

The CPEC is a network of infrastructure projects that are currently under construction throughout Pakistan that will connect China's Xinjiang province with Gwadar port in Pakistan's Balochistan province.

India, China should resolve border differences in a calm way, says Beijing

Hua also said that India and China should look at their border differences, including over Dokalam, in a "calm way" and resolve them through existing mechanisms.

Reacting to Bambawale's interview, she said that differences can be addressed through existing mechanisms. "Indeed we have noted that the ambassador talked about it while addressing the issue," the Chinese foreign ministry spokesperson said.

"I should say the two sides should look at border issues in a calm way and resolve relevant issues through the existing border-related mechanisms so that we can create conditions and enabling the environment to properly solve our differences," she added.

Besides a mechanism to discuss border tensions, India and China also have special representative-level border talks to resolve the differences over the disputed border.

About the new satellite imagery showing buildup by both sides, Hua reiterated that Dokalam, over which Bhutan also claims sovereignty, is Chinese territory and said China is building facilities in the area.

She referred to the 1890 treaty between UK and China and said, "the Sikkim section of the China-India boundary has been demarcated by historic treaty and treaty under effective jurisdiction of China".

"China has always upheld our sovereignty along the border area including (Dokalam) Donglang," Hua said. About the satellite imagery, she said, "I should stress it (area) falls within China's sovereignty that we conduct facility building in Donglang area. Some Indian media have carried reports about the military buildup and infrastructure building in the area. They are very excited about it."

India and China ended a tense 73-day standoff on August 28 last year at Dokalam area after the People's Liberation Army (PLA) stopped building a strategic road close to India's narrow Chicken's Neck area connecting the northeastern states. Bhutan also claims the Dokalam area to be its part.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 8,2024

covid.jpg

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.